PrimeRFP SCOUT · Federal Contract Recompete Brief

75F40125P00196 — PURCHASE ORDER FOR EVALUATION OF AN IN VITRO SPINAL ROSETTE ARRAY PLATFORM

PURCHASE ORDER FOR EVALUATION OF AN IN VITRO SPINAL ROSETTE ARRAY PLATFORM is a federal NONE award for Department of Health and Human Services (HHS) held by NEUROSETTA LLC. Estimated value $135K ($135K obligated). Current period of performance ends Sep 2, 2026. Last award drew 1 bidder. Place of performance: MADISON WI.

$135K
Estimated Value
Sep 2, 2026
PoP End / Expires
1
Bidders (last award)

Track this contract

Get an alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.

See related expiring contracts →

Analysis

Public

NEUROSETTA LLC holds $135K across 1 federal awards, concentrated at Department of Health and Human Services (HHS). The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: NONE. Recompete timing centers on the Sep 2, 2026 PoP end — agencies typically plan 12–18 months ahead.

Contract facts

NONE
Contract number75F40125P00196
AgencyDepartment of Health and Human Services (HHS)
IncumbentNEUROSETTA LLC
CAGE8WPS0
UEILKCCN9GN4BM1
NAICS541715
PSCAN13
Place of performanceMADISON WI
Pricing typeFirm Fixed Price
Extent competedNot Competed Under SAP
PoP startSep 5, 2025
PoP end (current)Sep 2, 2026
Obligated$135K
Current value$135K
Potential value$135K

PURCHASE ORDER FOR EVALUATION OF AN IN VITRO SPINAL ROSETTE ARRAY PLATFORM

Recompete timing

Public
Expiring in 13 days

Current PoP ends Sep 2, 2026 (13 days remaining). Agencies typically plan 12–18 months ahead — at 0.4 months out, that window is already open. The buying decision is likely already in motion.

Watch this contract — one email →

Incumbent footprint

Public record

NEUROSETTA LLC$135K obligated across 1 awards (firm-wide, all agencies).

Sole agency: Department of Health and Human Services (HHS)
Department of Health and Human Services (HHS)$135K · 100% of firm total
Open full company profile

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP

Track this contract

Get an alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.

See the recompete window for 75F40125P00196
More in SCOUT
Track this contract →

Alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.

Size up the competition →

See all live recompete landscapes — who else is expiring, and where the openings are.

Research the incumbent →

Open NEUROSETTA LLC’s federal contract profile — agency mix, recompete pipeline, and teaming relationships.

Frequently asked questions

What is contract 75F40125P00196?

75F40125P00196 (PURCHASE ORDER FOR EVALUATION OF AN IN VITRO SPINAL ROSETTE ARRAY PLATFORM) is a Department of Health and Human Services (HHS) award with an estimated value of $135K, currently held by NEUROSETTA LLC. Figures are USASpending-sourced public-record facts normalized by PrimeRFP SCOUT.

Who is the incumbent on 75F40125P00196?

NEUROSETTA LLC is the incumbent with $135K across 1 related awards in SCOUT’s public footprint. The current period of performance ends Sep 2, 2026.

When does 75F40125P00196 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 2, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows. Explore it live — $90 Pilot →

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/75F40125P00196

SCOUT Signal

August 2026

One VA health contract was 35% of civilian federal obligations in July.

Meanwhile VA's service-disabled veteran-owned contract actions fell 41.8%. The same agency, the same month, the large-vendor lane expanding while the small-business lane contracted. Figures are civilian-agency obligations through 2026-07-31; DoD FPDS for this window is labeled incomplete.

This issue is the whole civilian market. Your capture plan isn't.

Read the August 2026 issue →